US 7867974
Induction of tolerance by oral administration of factor VIII and treatment of hemophilia
granted A61KA61K38/27A61K38/36
Quick answer
US patent 7867974 (Induction of tolerance by oral administration of factor VIII and treatment of hemophilia) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/27, A61K38/36, A61K38/4846, A61K48/00